55
Gilgamesh Pharma Inc. raises $60M under Reg D
Company raise · Closed · Offering $60M · Sold $60M · NEW YORK, NY · filed 2026-03-24
47
Gilgamesh Pharma Inc. raises $2.3M under Reg D
Company raise · Raising · NEW YORK, NY · Form D filed 2026-03-31
$10M+ raise
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Amy Kruse | Director |
| Jonathan Sporn | Executive Officer, Director |
| Phil Skolnick | Director |
| Zia Huque | Director |
| Robert Berman | Director |
| Andrew Kruegel | Executive Officer, Director |
Signed by Jonathan Sporn, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
45
Gilgamesh Pharma Inc. raises $4.4M under Reg D
Company raise · Pre-first close · Offering $4.4M · NEW YORK, NY · filed 2026-02-04
45
Gilgamesh Pharma Inc. raises $6.1M under Reg D
Company raise · Closed · Offering $6.1M · Sold $6.1M · NEW YORK, NY · filed 2026-02-04